Aesthetic Medicine Market (By Procedure Type: Invasive Procedures, Non-invasive Procedures) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global aesthetic medicine market size was estimated at around USD 127.14 billion in 2023 and it is projected to hit around USD 511.67 billion by 2033, growing at a CAGR of 14.94% from 2024 to 2033.

Aesthetic Medicine Market Size 2024 to 2033

Key Pointers

  • North America dominated the market with the largest market share of 35% in 2023.
  • Asia Pacific region is anticipated to grow at the noteworthy CAGR from 2024 to 2033.
  • By Procedure, the non-invasive procedures segment generated the maximum market share of 56% in 2023.

Aesthetic Medicine Market Overview

The field of aesthetic medicine has experienced remarkable growth, propelled by evolving consumer preferences, advancements in technology, and an increasing emphasis on self-care and well-being. This burgeoning market encompasses a wide array of procedures and products aimed at enhancing physical appearance, boosting self-confidence, and promoting a sense of personal satisfaction.

Aesthetic Medicine Market Growth Factors

The growth of the aesthetic medicine market is driven by an evolving societal attitude towards beauty and self-care have normalized cosmetic procedures, driving increased demand. Technological advancements have led to safer and more effective treatments, expanding the options available to patients. Additionally, globalization and social media influence have fueled the desire for flawless appearance, particularly among younger demographics. Rising disposable incomes, especially in emerging economies, have further boosted market growth by increasing accessibility to aesthetic treatments. However, regulatory challenges and ethical considerations remain important factors to navigate in ensuring sustained growth and maintaining trust within the industry.

Aesthetic Medicine Market Trends:

  • Increased Acceptance: A notable trend in the aesthetic medicine market is the growing acceptance of cosmetic procedures among consumers. Societal attitudes towards beauty and self-enhancement have evolved, leading to a decrease in stigma and an increase in demand for aesthetic treatments.
  • Globalization of Beauty Standards: The globalization of beauty standards, fueled in part by social media, has contributed to the rise in demand for aesthetic treatments worldwide. As individuals strive to meet evolving beauty ideals, they increasingly turn to aesthetic procedures to achieve their desired appearance.
  • Personalization and Customization: A growing trend in the aesthetic medicine market is the demand for personalized and customized treatments. Patients seek tailored solutions that address their unique concerns and preferences, driving the development of specialized procedures and targeted skincare regimens.
  • Rise of Non-Invasive Procedures: Non-invasive or minimally invasive procedures are gaining popularity due to their lower risk, minimal downtime, and natural-looking results. Technologies such as lasers, radiofrequency, and ultrasound enable patients to achieve significant aesthetic improvements without the need for surgery, reflecting a shift towards more conservative treatment approaches.
  • Emphasis on Prevention and Maintenance: With an increasing emphasis on wellness and longevity, there is a growing demand for preventive and maintenance-focused aesthetic treatments. Patients are seeking proactive solutions to address signs of aging and maintain youthful vitality, driving the demand for anti-aging skincare regimens and preventive procedures.

Aesthetic Medicine Market Challenges:

  • Safety Concerns: Safety remains a significant concern within the aesthetic medicine industry, particularly with the proliferation of minimally invasive procedures and cosmetic injectables. Ensuring the safety and efficacy of treatments, as well as properly managing potential risks and complications, is essential to maintaining patient trust and confidence in the industry.
  • Ethical Considerations: The ethical implications of aesthetic medicine, particularly regarding body image, beauty standards, and patient autonomy, present ongoing challenges for practitioners and stakeholders. Balancing the desire for aesthetic enhancement with ethical principles such as informed consent, patient autonomy, and psychological well-being requires careful consideration and ethical decision-making.
  • Professional Standards and Training: Maintaining high professional standards and ensuring adequate training and certification for practitioners is essential for delivering safe and effective aesthetic treatments. However, the lack of standardized training programs and varying levels of expertise among providers pose challenges to ensuring consistent quality of care and patient outcomes.
  • Misinformation and Misleading Marketing: The proliferation of misinformation and misleading marketing practices in the aesthetic medicine industry can undermine patient trust and confidence. Patients may be exposed to exaggerated claims, unrealistic expectations, and deceptive advertising, leading to dissatisfaction, dissatisfaction, and potential harm

Procedure Type Insights

The aesthetic medicine industry is segmented based on procedure type into invasive and non-invasive procedures. In 2023, the non-invasive procedures segment held the majority share of 56% in the market and is projected to experience the fastest growth rate throughout the forecast period. Factors such as minimal discomfort, immediate results, and affordability have fueled the global demand for non-invasive procedures. Common non-invasive treatments include Botox injections, soft tissue fillers, and chemical peels. Additionally, invasive procedures like liposuction, breast augmentation, and rhinoplasty remain popular choices among individuals seeking aesthetic enhancements. The increasing emphasis on physical appearance has contributed to the rising demand for these invasive procedures.

Regional Insights

In 2023, North America commanded the largest share, accounting for 35% of the global aesthetic medicine market revenue. The region's robust healthcare infrastructure, widespread adoption of cosmetic procedures, increasing prevalence of skin disorders, and the presence of numerous certified and skilled cosmetic surgeons are key factors driving market growth in North America.

According to data from the International Society of Aesthetic Plastic Surgery (ISAPS) in 2022, the United States alone witnessed a significant number of aesthetic procedures, totaling 7,448,196. This highlights the enduring popularity and demand for aesthetic enhancements in the country, thereby propelling the U.S. aesthetic medicine market forward.

The Asia Pacific region is expected to exhibit the highest compound annual growth rate (CAGR) during the forecast period. This growth is fueled by countries such as China, India, Malaysia, and South Korea. Factors contributing to the region's growth include the availability of technologically advanced products and a growing emphasis on physical appearance. Furthermore, South Korea's reputation as a leading center for cosmetic surgeries serves as a significant driver for regional market expansion.

Aesthetic Medicine Market Key Companies

  • AbbVie
  • Cynosure
  • Evolus Inc.
  • Revance Galderma
  • Lumenis
  • Solta Medical
  • Syneron Candela
  • Alma Laser

Aesthetic Medicine Market Segmentations:

By Procedure

  • Invasive Procedures
    • Breast augmentation
    • Liposuction
    • Nose reshaping
    • Eyelid Surgery
    • Tummy tuck
    • Others
  • Non-invasive Procedures
    • Botox injections
    • Soft tissue fillers
    • Chemical peel
    • Laser hair removal
    • Microdermabrasion
    • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global aesthetic medicine market size was reached at USD 127.14 billion in 2023 and it is projected to hit around USD 511.67 billion by 2033.

The global aesthetic medicine market is growing at a compound annual growth rate (CAGR) of 14.94% from 2024 to 2033.

The North America region has accounted for the largest aesthetic medicine market share in 2023.

Chapter 1. Introduction

1.1. Research Objective                    

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Aesthetic Medicine Market

5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape List of Suppliers List of Buyers

Chapter 8. Global Aesthetic Medicine Market, By Procedure

8.1.Aesthetic Medicine Market, by Procedure Type, 2024-2033

8.1.1. Invasive Procedures Market Revenue and Forecast (2021-2033)

8.1.2. Non-invasive Procedures Market Revenue and Forecast (2021-2033)

Chapter 9. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Procedure (2021-2033)

9.1.2. U.S. Market Revenue and Forecast, by Procedure (2021-2033)

9.1.3. Rest of North America Market Revenue and Forecast, by Procedure (2021-2033)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Procedure (2021-2033)

9.2.2. UK Market Revenue and Forecast, by Procedure (2021-2033)

9.2.3. Germany Market Revenue and Forecast, by Procedure (2021-2033)

9.2.4. France Market Revenue and Forecast, by Procedure (2021-2033)

9.2.5. Rest of Europe Market Revenue and Forecast, by Procedure (2021-2033)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Procedure (2021-2033)

9.3.2. India Market Revenue and Forecast, by Procedure (2021-2033)

9.3.3. China Market Revenue and Forecast, by Procedure (2021-2033)

9.3.4. Japan Market Revenue and Forecast, by Procedure (2021-2033)

9.3.5. Rest of APAC Market Revenue and Forecast, by Procedure (2021-2033)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Procedure (2021-2033)

9.4.2. GCC Market Revenue and Forecast, by Procedure (2021-2033)

9.4.3. North Africa Market Revenue and Forecast, by Procedure (2021-2033)

9.4.4. South Africa Market Revenue and Forecast, by Procedure (2021-2033)

9.4.5. Rest of MEA Market Revenue and Forecast, by Procedure (2021-2033)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Procedure (2021-2033)

9.5.2. Brazil Market Revenue and Forecast, by Procedure (2021-2033)

9.5.3. Rest of LATAM Market Revenue and Forecast, by Procedure (2021-2033)

Chapter 10. Company Profiles

10.1. AbbVie

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. Cynosure

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Evolus Inc.

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. Revance Galderma

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Lumenis

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Solta Medical

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Syneron Candela

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. Alma Laser

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3.Financial Performance

10.8.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers